Categories: News

Pasaca Capital Founder and Chairman Dr. Charles Huang Honored by California Joint AAPI Legislative Caucus

PASADENA, Calif., May 10, 2022 /PRNewswire/ — Charles Huang, PhD, Founder and Chairman of Pasaca Capital, Inc and Chairman of the Charles Huang Foundation, was recognized yesterday as one of the distinguished AAPI leaders and received the honor of Excellence in Business in Sacramento by the California Joint Asian American & Pacific Islander (AAPI) Legislative Caucus. 

The AAPI legislative Caucus recognized eight leaders in eight different categories in the ceremony. Each individual leader was honored for their willingness to step up and lead their community through challenging times during COVID.

“These leaders not only led but uplifted our community during a time when we needed it most. These honorees elevated AAPI voices and insisted that our community be visible and heard in our country,” said Dr. Richard Pan, Senator (D-Sacramento) and Chair of the Joint AAPI Legislative Caucus.

Dr Huang founded Pasaca Capital Inc. in 2016 in Pasadena, California with a focus on medical devices, pharmaceuticals, TMT, industrial & automation, and food ingredient sectors. One of Pasaca Capital’s portfolio companies, Innova Medical Group Inc. is the global leader in COVID-19 antigen rapid testing manufacturing and distribution and has delivered approx. 2 billion tests kits to the UK government and other customers worldwide.

“I’m very humbled to be recognized in Asian American and Pacific Islander Heritage month,” said Dr. Huang. “This award will compel me to do more to help the world, especially our State and local communities.”

In November 2021, Dr. Huang was named “2021 Philanthropreneur of the Year by the California State Assembly in recognition of the exceptional leadership in donating $110 million to the education sector in 2021. Pasaca Capital was also named 2021 Business of the Yearby the California State Assembly for its extraordinary contributions to the State of California and the world.

About Pasaca Capital, Inc
Pasaca Capital Inc. is a California-based private equity investment firm focused on innovative technologies and products that improve the human condition. With a focus on medical devices, pharmaceuticals, TMT, industrial & automation, and food sectors, Pasaca portfolio companies including, Innova Medical Group, Inc, PDTI, Claire, Sweegen Inc, Meepo Inc., ATL Group Ltd, ASOCS, Caton Technology, and others, operate globally. www.pasacacapital.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/pasaca-capital-founder-and-chairman-dr-charles-huang-honored-by-california-joint-aapi-legislative-caucus-301544094.html

SOURCE Pasaca Capital, Inc.

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

5 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

8 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

8 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

8 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

8 hours ago

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…

8 hours ago